The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE

Clinical and Experimental Immunology

Volumn 142, Issue 1, 2005, Pages 21-30

  Chen, L ^a   Lin, S X ^a   Overbergh, L ^c   Mathieu, C ^c   Chan, Lawrence S ^a,b,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Atopic dermatitis; B cell activation; IgE; Proliferation

Indexed keywords

CELL MARKER; CYTOKERATIN 14; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DISEASE COURSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL DIVISION; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; KERATIN-14; KERATINOCYTES; KERATINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MICE; MICE, TRANSGENIC; RNA, MESSENGER; SPLEEN; UP-REGULATION;

EID: 25444517290     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02894.x     Document Type: Article

References (28)

1. Kallstrom E, Roscher I, Andreasson A, Back O, van Hage-Hamsten M. Decreased frequency of intracellular IFN-gamma producing T cells in whole blood preparations from patients with atopic dermatitis. Exp Dermatol 2002; 11:556-63.
2. Jones HE, Inouye JC, McGerity JL, Lewis CW. Atopic disease and serum immunoglobulin-E. Br J Dermatol 1975; 92:17-25.
3. Jones HE, Wade TR. Relationship between atopic dermatitis and immunoglobulin E. Int J Dermatol 1976; 15:293-6.
4. Ohman S, Johansson SG. Immunoglobulins in atopic dermatitis with special reference to IgE. Acta Derm Venereol 1974; 54:193-202.
5. Novak N, Kraft S, Bieber T. Unraveling the mission of FcepsilonRI on antigen-presenting cells. J Allergy Clin Immunol 2003; 111:38-44.
6. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94:870-6.
7. Toda M, Leung DY, Molet S et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003; 111:875-81.
8. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003; 3:721-32.
9. Kawashima T, Noguchi E, Arinami T et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998; 35:502-4.
10. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117:977-83.
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:44-7.
12. Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS, Chan LS. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004; 138:375-87.
13. Chen L, Martinez O, Venkataramani P, Lin SX, Prabhakar BS, Chan LS. Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis. Clin Exp Immunol 2005; 139:189-201.
14. Sambrook J, Russell DW. Molecular Cloning, a Laboratory Manual, 3rd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 2001.
15. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR. applications to quantify cytokine gene expression. Methods 2001; 25:386-401.
16. Finkelman FD, Katona IM, Urban JF Jr, Paul WE. Control of in vivo IgE production in the mouse by interleukin 4. Ciba Found Symp 1989; 147:3-22.
17. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994; 12:456-65.
18. Marzio R, Mauel J, Betz-Corradin S. CD69 and the regulation of the immune function. Immunopharmacol Immunotoxicol 1999; 21:565-82.
19. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol 1999; 52:189-96.
20. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10:423-8.
21. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54:271-335.
22. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7:213-21.
23. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecule to signaling regulators. Nat Rev Mol Cell Biol 2003; 4:33-45.
24. Murakami S, Miyake K, Kincade PW, Hodes RJ. Functional role of CD44 (Pgp-1) on activated B cells. Immunol Res 1991; 10:15-27.
25. Ranheim EA, Kipps TJ. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 1995; 161:226-35.
26. Kennedy MK, Mohler KM, Shanebeck KD et al. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur J Immunol 1994; 24:116-23.
27. Shahinian A, Pfeffer K, Lee KP et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993; 261:609-12.
28. Mond JJ, Seghal E, Kung J, Finkelman FD. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J Immunol 1981; 127:881-8.